Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

In Vivo Targeting of ADAM9 Gene Expression Using Lentivirus-Delivered shRNA Suppresses Prostate Cancer Growth by Regulating REG4 Dependent Cell Cycle Progression

  • Che-Ming Liu ,

    Contributed equally to this work with: Che-Ming Liu, Chia-Ling Hsieh

    Affiliation Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan, ROC

  • Chia-Ling Hsieh ,

    Contributed equally to this work with: Che-Ming Liu, Chia-Ling Hsieh

    Affiliations Graduate Institutes of Cancer Biology, China Medical University, Taichung, Taiwan, ROC, Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan, ROC, Department of Biotechnology, Asia University, Wufeng, Taichung, Taiwan, ROC

  • Yun-Chi He,

    Affiliation Graduate Institutes of Cancer Biology, China Medical University, Taichung, Taiwan, ROC

  • Sen-Jei Lo,

    Affiliation Graduate Institutes of Cancer Biology, China Medical University, Taichung, Taiwan, ROC

  • Ji-An Liang,

    Affiliation Division of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan, ROC

  • Teng-Fu Hsieh,

    Affiliations Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan, ROC, Division of Urology, Buddhist Tzu-Chi General Hospital, Taichung Branch, Taichung, Taiwan, ROC, Department of Urology, School of Medicine, Buddhist Tzu Chi University, Hualien, Taiwan, ROC

  • Sajni Josson,

    Affiliation Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America

  • Leland W. K. Chung,

    Affiliation Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America

  • Mien-Chie Hung,

    Affiliations Graduate Institutes of Cancer Biology, China Medical University, Taichung, Taiwan, ROC, Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan, ROC, Department of Biotechnology, Asia University, Wufeng, Taichung, Taiwan, ROC, Department of Molecular and Cellular Oncology, M.D. Anderson Cancer Center, University of Texas, Houston, Texas, United States of America

  • Shian-Ying Sung

    ssung@mail.cmu.edu.tw

    Affiliations Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan, ROC, Graduate Institutes of Cancer Biology, China Medical University, Taichung, Taiwan, ROC, Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan, ROC

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.